+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Next Generation RNA Sequencing"

NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Thumbnail Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • April 2024
  • 196 Pages
  • Global
From
NGS-Based RNA-Sequencing Global Market Report 2024 - Product Thumbnail Image

NGS-Based RNA-Sequencing Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

The Next Generation RNA Sequencing (NGS) market is a rapidly growing segment of the genomics industry. NGS is a powerful tool for studying gene expression, which is the process by which genetic information is used to produce proteins and other molecules. NGS enables researchers to analyze the expression of thousands of genes simultaneously, providing a comprehensive view of gene expression in a single experiment. This technology has been used to study a wide range of biological processes, including cancer, neurological disorders, and infectious diseases. NGS has also been used to identify novel biomarkers and therapeutic targets, as well as to develop personalized medicine. In addition, NGS has enabled researchers to study the evolution of genes and to identify genetic variants associated with disease. Companies in the Next Generation RNA Sequencing market include Illumina, Thermo Fisher Scientific, BGI, Oxford Nanopore Technologies, Pacific Biosciences, and 10X Genomics. Show Less Read more